A G Protein-coupled Receptor Responsive to Bile Acids
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
So far some nuclear receptors for bile acids have been identified. However, no cell surface receptor for bile acids has yet been reported. We found that a novel G protein-coupled receptor, TGR5, is responsive to bile acids as a cell-surface receptor. Bile acids specifically induced receptor internalization, the activation of extracellular signal-regulated kinase mitogen-activated protein kinase, the increase of guanosine 5'-O-3-thio-triphosphate binding in membrane fractions, and intracellular cAMP production in Chinese hamster ovary cells expressing TGR5. Our quantitative analyses for TGR5 mRNA showed that it was abundantly expressed in monocytes/macrophages in human and rabbit. Treatment with bile acids was found to suppress the functions of rabbit alveolar macrophages including phagocytosis and lipopolysaccharide-stimulated cytokine productions. We prepared a monocytic cell line expressing TGR5 by transfecting a TGR5 cDNA into THP-1 cells that did not express TGR5 originally. Treatment with bile acids suppressed the cytokine productions in the THP-1 cells expressing TGR5, whereas it did not influence those in the original THP-1 cells, suggesting that TGR5 is implicated in the suppression of macrophage functions by bile acids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, KO of the BA receptors FXR (Nr1h4), TGR5 (Gpbar1), and VDR (Vdr) (36-38) did not rescue T cell function in LCA-fed mice (fig. S10, F and G).”
From Bile acid synthesis impedes tumor-specific T cell responses during liver cancer (2025) · cites this paper as [36]
In the citing paper
“activation of GPBAR1 on macrophages and Kupffer cells by synthetic agonists inhibits the expression of LPS-induced pro-inflammatory cytokines by interfering with NF-κB-dependent transcription.”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“Both receptors can be activated by primary and secondary bile acids alike (Kawamata et al., 2003; Makishima et al., 1999; Maruyama et al., 2002; Parks et al., 1999; H. Wang et al., 1999).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“GPBAR1, as the name suggests, is a Gs-protein-coupled receptor. Binding by bile acids triggers an increase in intracellular cAMP levels and the activation of ERK (Kawamata et al., 2003; Maruyama et al., 2002).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
In the citing paper
“This has been linked to direct inhibition of NF-κB activation, but is also consistent with a model of transcriptional competition between NF-κB and the cAMP-activated transcription factor cAMP response element binding protein (CREB) (C. Guo et al., 2015; Kawamata et al., 2003; Keitel et al., 2008; Pols et al., 2011; Y.-D. Wang et al., 2011; Wen et al., 2010).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Kawamata et al., 2003
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
Xu, Y., Zhu, K., Hong, G., Wu, W., Baudhuin, L. M., Xiao, Y.-J., & Damron, D. S. (2000) · Nature Cell Biology · doi:10.1038/35010529 · Cited by 289
RetractedCD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
SOSUI: classification and secondary structure prediction system for membrane proteins.
Hirokawa, T., Boon-Chieng, S., & Mitaku, S. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.4.378 · Cited by 1,936
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
Russell, D. W., & Setchell, K. D. R. (1992) · Biochemistry · doi:10.1021/bi00135a001 · Cited by 819
The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution
Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C. O., LeCluyse, E. L., Lambert, M. H., Willson, T. M., et al. (2000) · Molecular Endocrinology · doi:10.1210/me.14.1.27 · Cited by 672
Research works printed but not linked: 3
- Jones, 2000, Mol. Endocrinol., 14, 27, 10.1210/mend.14.1.0409 · doi:10.1210/mend.14.1.0409 · Paper page
- Keane, 1984, Surgery, 95, 439
- Kimmings, 1995, J. Am. Coll. Surg., 181, 567
Cited by
Items 501–600 of 1,002
Bass, J. Y., Caravella, J. A., Chen, L., Creech, K. L., Deaton, D. N., Madauss, K. P., Marr, H. B., McFadyen, R. B., Miller, A. B., Mills, W. Y., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.089 · Cited by 62
Role of thyroid receptor β in lipid metabolism
Pramfalk, C., Pedrelli, M., & Parini, P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.019 · Cited by 70
Renga, B., Bucci, M., Cipriani, S., Carino, A., Monti, M. C., Zampella, A., Gargiulo, A., d'Emmanuele di Villa Bianca, R., Distrutti, E., & Fiorucci, S. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00087.2015 · Cited by 59
Cao, H., Chen, Z., Wang, K., Ning, M., Zou, Q., Feng, Y., Ye, Y., Leng, Y., & Shen, J. (2016) · Scientific Reports · doi:10.1038/srep28676 · Cited by 62
“TGR5 (Takeda G-protein-coupled receptor 5), also known as GPBAR1, M-BAR, or GPCR19, was identified first as a G protein-coupled receptor responsive to bile acids (BAs) in 2002 1,2 .”
Determinants of postprandial plasma bile acid kinetics in human volunteers
Fiamoncini, J., Yiorkas, A. M., Gedrich, K., Rundle, M., Alsters, S., Roeselers, G., van den Broek, T. J., Clavel, T., Lagkouvardos, I., Wopereis, S., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00157.2017 · Cited by 63
“TGR5 74 activation by BA was shown to activate deiodinase, increasing the level of active thyroid 75 hormone which in turn elevates the expression of enzymes involved in fatty acid oxidation 76 in brown adipose tissue and skeletal muscle(24, 28, 39, 43, 57, 60, 64, 66).”
BackgroundInfluentialJena, P. K., Sheng, L., Nagar, N., Wu, C., Barile, D., Mills, D. A., & Wan, Y.-J. Y. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.04.007 · Cited by 60
“Another TGR5 ligand, hepatic lithocholic acid (LCA) was increased by B. infantis and a combination of B. infantis plus MO.”
BackgroundInfluentialJouihan, H., Will, S., Guionaud, S., Boland, M. L., Oldham, S., Ravn, P., Celeste, A., & Trevaskis, J. L. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.09.001 · Cited by 59
“to GLP-1 function via activation of FXR and/or the cell surface receptor TGR5, which has been reported to stimulate the release of GLP-1 in vitro [32,33].”
BackgroundRoda, A., Pellicciari, R., Gioiello, A., Neri, F., Camborata, C., Passeri, D., Franco, F., Spinozzi, S., Colliva, C., Adorini, L., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214650 · Cited by 65
“Because FXR (Makishima et al., 1999; Parks et al., 1999; Kalaany and Mangelsdorf, 2006; Lefebvre et al., 2009) and TGR5 (Kawamata et al., 2003; Keitel et al., 2007, 2008, 2009; Poole et al., 2010) expression overlaps in some but not all tissues, OCA, INT777, and INT-767 biodistribution should…”
BackgroundIncreased bile acids in enterohepatic circulation by short-term calorie restriction in male mice
Fu, Z. D., & Klaassen, C. D. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.020 · Cited by 56
“There are two major BA receptors, namely the nuclear receptor farnesoid X receptor (FXR/Nr1h4) (Makishima et al., 1999; Parks et al., 1999; Wang et al., 1999) and the membrane-bound G-protein coupled receptor TGR5 (GPBAR1) (Kawamata et al., 2003).”
BackgroundThe gut microbiota: a key regulator of metabolic diseases
Yang, J., & Kweon, M. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.10.144 · Cited by 64
“Additional studies have suggested that bile acid-TGR5-cAMP signaling pathways enhance energy expenditure in adipose tissue (46, 47).”
BackgroundInfluentialBile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2–Mediated Water Homeostasis
Li, S., Qiu, M., Kong, Y., Zhao, X., Choi, H.-J., Reich, M., Bunkelman, B. H., Liu, Q., Hu, S., Han, M., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018030271 · Cited by 59
Bile acid toxicity in Paneth cells contributes to gut dysbiosis induced by high-fat feeding
Zhou, H. J., Zhou, S.-Y., Gillilland, M. G., Li, J., Lee, A. A., Gao, J. L., Zhang, G., Xu, X., & Owyang, C. (2020) · JCI Insight · doi:10.1172/jci.insight.138881 · Cited by 61
“Both primary and secondary bile acids exert their effects by activating nuclear (15) and plasma membrane receptors (16, 17).”
NOX as a Therapeutic Target in Liver Disease
Matuz‐Mares, D., Vázquez‐Meza, H., & Vilchis‐Landeros, M. M. (2022) · Antioxidants · doi:10.3390/antiox11102038 · Cited by 65
“Additionally, by being a ligand for the G-protein coupled receptor TGR5 [101] and activating mitogen-activated protein kinase pathways [102], they contribute to several additional cell signaling and immunoregulatory processes [103,104].”
BackgroundYntema, T., Koonen, D. P. Y., & Kuipers, F. (2023) · Nutrients · doi:10.3390/nu15081850 · Cited by 59
Keitel, V., & Häussinger, D. (2011) · Digestive Diseases · doi:10.1159/000324127 · Cited by 56
“TGR5 (Gpbar-1) is a plasma membrane-bound bile acid receptor, which is expressed in many rodent and human tissues, including liver. TGR5 is coupled to a stimulatory G-protein and activation of TGR5 by bile acids leads to a rise in intracellular cyclic AMP (cAMP) concentrations [”
BackgroundPostprandial gut hormone responses and glucose metabolism in cholecystectomized patients
Sonne, D. P., Hare, K. J., Martens, P. C., Rehfeld, J. F., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00435.2012 · Cited by 64
“Bile acids are ligands of the nuclear farnesoid X receptor (FXR), a receptor (expressed in high concentrations in the liver and intestines) that is implicated in glucose control (3), and they also signal through the cell surface G protein-coupled receptor TGR5, which is known to modulate energy expenditure in brown fa…”
BackgroundGarcia, M., Thirouard, L., Sèdes, L., Monrose, M., Holota, H., Caira, F., Volle, D. H., & Beaudoin, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113630 · Cited by 62
“also known as NR1I1) and the cell-surface receptor TGR5 (also known as GPBAR1; G-protein coupled bile acid receptor 1), which are outside of the scope of this review [15,16], these three NRs exert their functions as sensors of BA levels, and elicit transcriptional alterations in order to regulate BA homeostasis, as di…”
BackgroundSynthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5
Herbert, M. R., Siegel, D. L., Staszewski, L. M., Cayanan, C. S., Banerjee, U., Dhamija, S., Anderson, J., Fan, A., Wang, L., Rix, P. J., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.014 · Cited by 61
TGR5: Pathogenetic Role and/or Therapeutic Target in Fibrosing Cholangitis?
Keitel, V., Reich, M., & Häussinger, D. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-014-8443-x · Cited by 59
“TGR5 expression has not been detected in CD4-/CD8- or CD19-positive lymphocytes [26].”
BackgroundWard, J. B. J., Mroz, M. S., & Keely, S. J. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12148 · Cited by 55
Yu, H., Ni, Y., Bao, Y., Zhang, P., Zhao, A., Chen, T., Xie, G., Tu, Y., Zhang, L., Su, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2884 · Cited by 58
Guo, C., Su, J., Li, Z., Xiao, R., Wen, J.-X., Li, Y., Zhang, M., Zhang, X., Yu, D. D., Huang, W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5353 · Cited by 59
“The bile acid receptor TGR5 is a regulator of energy homeostasis, bile acid homeostasis as well as glucose metabolism [11].”
BackgroundCharacterization of AQPs in Mouse, Rat, and Human Colon and Their Selective Regulation by Bile Acids
Yde, J., Keely, S. J., Wu, Q., Borg, J. F., Lajczak, N., O’Dwyer, A. M., Dalsgaard, P., Fenton, R. A., & Moeller, H. B. (2016) · Frontiers in Nutrition · doi:10.3389/fnut.2016.00046 · Cited by 59
Fiorucci, S., Zampella, A., Cirino, G., Bucci, M., & Distrutti, E. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00577.2016 · Cited by 55
“GPBAR1 is a G protein-coupled receptor that is preferentially activated by conjugated and unconjugated secondary bile acids, DCA and LCA (33).”
BackgroundGq and Gs signaling acting in synergy to control GLP-1 secretion.
Hauge, M., Ekberg, J. H., Engelstoft, M., Timshel, P., Madsen, A. N., & Schwartz, T. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.024 · Cited by 50
Nizamutdinov, D., DeMorrow, S., McMillin, M., Kain, J., Mukherjee, S., Zeitouni, S., Frampton, G., Bricker, P. C. S., Hurst, J., & Shapiro, L. A. (2017) · Scientific Reports · doi:10.1038/srep40112 · Cited by 54
Metabolic regulation in the immune response to cancer
Wu, Q., Yu, X., Li, J., Sun, S., & Tu, Y. (2021) · 癌症:英文版 · doi:10.1002/cac2.12182 · Cited by 64
“The activation of GPBAR1 by BAs contributes to increased intracellular cAMP levels, which activate extracellular signal-regulated kinases [230].”
BackgroundClinical application of transcriptional activators of bile salt transporters
Baghdasaryan, A., Chiba, P., & Trauner, M. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.12.001 · Cited by 60
Discovery of new G protein-coupled receptors for lipid mediators
Im, D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300006-jlr200 · Cited by 61
“Although bile acids have nuclear receptors [farnesoid X receptor (nuclear bile acid receptor) (FXR)], the TGR5-mediated responses of bile acids are distinguishable from the nuclear receptor-mediated responses in three aspects: GPCR-mediated responses are much faster than responses through nuclear receptors, expression…”
BackgroundResultInfluentialGether, I. M., Nexøe-Larsen, C., & Knop, F. K. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01008 · Cited by 56
Zangerolamo, L., Carvalho, M. U. W. B. D., & Barbosa, H. C. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146547 · Cited by 61
“The G-protein-α s subunit subsequently stimulates adenylyl cyclase, leading to an increase in cyclic adenosine monophosphate (cAMP) levels and activation of protein kinase A (PKA), thereby initiating further downstream signaling pathways [10,13].”
InfluentialCipriani, S., Renga, B., D’Amore, C., Simonetti, M., Tursi, A. A. D., Carino, A., Monti, M. C., Sepe, V., Zampella, A., & Fiorucci, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129866 · Cited by 56
Camilleri, M., Vazquez-Roque, M. I., Carlson, P., Burton, D., Wong, B. S., & Zinsmeister, A. R. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01772.x · Cited by 55
Meyer-Gerspach, A. C., Steinert, R. E., Keller, S., Malarski, A., Schulte, F. H., & Beglinger, C. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4109 · Cited by 52
“BAs are ligands for the membraneGprotein-coupled receptor,TGR5(2,3), and the nuclear farnesoid X receptor (FXR) (4), both of which seem to be involved in the signaling properties of BAs.”
BackgroundBile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases
Stanimirov, B., Stankov, K., & Mikov, M. (2015) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(14)60307-6 · Cited by 59
Patented TGR5 modulators: a review (2006 – present)
Gioiello, A., Rosatelli, E., Nuti, R., Macchiarulo, A., & Pellicciari, R. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.733000 · Cited by 58
“In response to BA binding, TGR5 activation induces the production of cytosolic cyclic adenosine monophosphate (cAMP) that triggers the protein kinase A (PKA), which in turn phosphorylates the cAMPresponse element binding protein (CREB) and modulates the transcription of its target genes [6,7].”
BackgroundInfluentialIntestinal bile acid receptors are key regulators of glucose homeostasis
Trabelsi, M.-S., Lestavel, S., Staels, B., & Collet, X. (2017) · Proceedings of the Nutrition Society · doi:10.1017/s0029665116002834 · Cited by 51
“First described as a regulator of cytokine production in a human monocyte cell line((14)), TGR5 is expressed in Küpffer cells, cholangiocytes, adipocytes, myocytes and enteroendocrine cells.”
BackgroundCycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling
Gu, M., Zhang, S., Zhao, Y., Huang, J., Wang, Y., Li, Y., Fan, S., Yang, L., Ji, G., Tong, Q., et al. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.021 · Cited by 59
Carino, A., Marchianò, S., Biagioli, M., Bucci, M., Vellecco, V., Brancaleone, V., Fiorucci, C., Zampella, A., Monti, M. C., Distrutti, E., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801373rr · Cited by 56
“GPBAR1 is highly expressed by cells of myeloid lineage, including macrophages andNKcells (12, 13, 17), and its activation is known to contribute to maintaining tolerogenic macrophages in the liver and intestine (17, 49–51).”
BackgroundAnti-inflammatory, anti-oxidative stress and novel therapeutic targets for cholestatic liver injury
Zhang, Y., Lu, Y., Ji, H. L., & Li, Y. (2019) · BioScience Trends · doi:10.5582/bst.2018.01247 · Cited by 57
Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome
Portincasa, P., Ciaula, A. D., Garruti, G., Vacca, M., Angelis, M. D., & Wang, D. Q. ‐. (2020) · Nutrients · doi:10.3390/nu12123709 · Cited by 60
“The tertiary BA (UDCA) has the lowest affinity for GPBAR-1 (EC50: 36 μM) [76,81].”
Background5β-Reduced steroids and human Δ4-3-ketosteroid 5β-reductase (AKR1D1)
Chen, M., & Penning, T. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.01.013 · Cited by 55
“Li T, Holmstrom SR, Kir S, Umetani M, Schmidt DR, Kliewer SA, et al. The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling.”
BackgroundInfluentialTaurochenodeoxycholic acid mediates cAMP-PKA-CREB signaling pathway
Qi, Y., Duan, G., Wei, M. A. O., Liu, Q., Zhang, Y., & Li, P. (2020) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(20)60033-4 · Cited by 55
Bile Acid Sequestrants: Glucose-Lowering Mechanisms and Efficacy in Type 2 Diabetes
Hansen, M., Sonne, D. P., & Knop, F. K. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0482-4 · Cited by 61
Sugita, T., Amano, K., Nakano, M., Masubuchi, N., Sugihara, M., & Matsuura, T. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/717431 · Cited by 59
Prawitt, J., Caron, S., & Staels, B. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.03.007 · Cited by 58
Prandi, S., Voigt, A., Meyerhof, W., & Behrens, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2621-y · Cited by 61
“This does not necessarily imply that Tas2r117 in the colon acts as a bile acid sensing receptor as another GPCR, the TGR5 (also known as GPBAR1) [90], is devoted to this role, however, Tas2r117 could be available to sense one of its other agonists in the absence of overwhelming bile acid concentrations.”
BackgroundCarino, A., Cipriani, S., Marchianò, S., Biagioli, M., Scarpelli, P. T., Zampella, A., Monti, M. C., & Fiorucci, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-13102-y · Cited by 63
Lin, S., Yang, X., Yuan, P., Yang, J., Wang, P., Zhong, H., Zhang, X., Che, L., Feng, B., Li, J., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01332 · Cited by 57
The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver
Klindt, C., Reich, M., Hellwig, B., Stindt, J., Rahnenführer, J., Hengstler, J. G., Köhrer, K., Schoonjans, K., Häussinger, D., & Keitel, V. (2019) · Cells · doi:10.3390/cells8111467 · Cited by 57
The pathophysiological function of non-gastrointestinal farnesoid X receptor
Yan, N., Yan, T., Xia, Y., Hao, H., Wang, G., & Gonzalez, F. J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107867 · Cited by 58
Physiological activation of human and mouse bitter taste receptors by bile acids
Ziegler, F., Steuer, A., Pizio, A. D., & Behrens, M. (2023) · Communications Biology · doi:10.1038/s42003-023-04971-3 · Cited by 56
Bile acid metabolism regulatory network orchestrates bone homeostasis
Xiang, T., Deng, Z., Yang, C. H., Tan, J., Dou, C., Luo, F., & Chen, Y. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106943 · Cited by 56
Cellular and Molecular Biology of Orphan G Protein‐Coupled Receptors
Oh, D. Y., Kim, K., Kwon, H. B., & Seong, J. Y. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)52003-0 · Cited by 59
Therapeutic targets for cholestatic liver injury
Woolbright, B. L., & Jaeschke, H. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1103735 · Cited by 54
“The recently discovered G-protein-coupled bile acid receptor (GPBAR or hereafter referred to as TGR5) is a novel receptor for bile acids expressed on multiple different cell types.[37] TGR5 is expressed on monocytes, sinusoidal endothelial cells, Kupffer cells, cholangiocytes, and to a lesser degree, hepatocytes in th…”
BackgroundFlowers, S. A., & Ellingrod, V. L. (2015) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1640 · Cited by 52
Role of the G Protein-Coupled Bile Acid Receptor TGR5 in Liver Damage
Reich, M., Klindt, C., Deutschmann, K., Spomer, L., Häussinger, D., & Keitel, V. (2017) · Digestive Diseases · doi:10.1159/000450917 · Cited by 53
Reciprocal interactions between bile acids and gut microbiota in human liver diseases
Ikegami, T., & Honda, A. (2018) · Hepatology Research · doi:10.1111/hepr.13001 · Cited by 55
McMurdie, P. J., Stoeva, M. K., Justice, N., Nemchek, M. P., Sieber, C. M. K., Tyagi, S., Gines, J., Skennerton, C. T., Souza, M., Kolterman, O., et al. (2022) · BMC Microbiology · doi:10.1186/s12866-021-02415-8 · Cited by 58
“Abbreviations AHAS: Acetohydroxyacid synthase (EC 2.2.1.6); AMUC: Akkermansia muciniphila strain AMUC; BCAA : Branched chain amino acids; BINF: Bifidobacterium infantis strain BINF; CA: Cholic acid; CBEI: Clostridium beijerinckii strain CBEI; CBUT: Clostridium butyricum strain CBUT; (G)CDCA: (glyco-)chenodeoxycholic a…”
BackgroundInfluentialA cross talk between microbial metabolites and host immunity: Its relevance for allergic diseases
Losol, P., Wolska, M., Wypych, T. P., Yao, L., O’Mahony, L., & Sokołowska, M. (2024) · Clinical and Translational Allergy · doi:10.1002/clt2.12339 · Cited by 56
“55 GPBAR1 activation by taurolithocholic acid (TLCA) down-regulated expression of pro ‐ inflammatory signaling in human macrophages, shifting classically activated macrophages (M1) to Abbreviations: CCL20, C ‐”
BackgroundLieu, T., Jayaweera, G., & Bunnett, N. W. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12426 · Cited by 52
“monocytes (Kawamata et al., 2003), sinusoidal endothelial cells, Kupffer cells (Keitel et al.”
BackgroundInfluentialSchepetkin, I. A., Khlebnikov, А. I., Giovannoni, M. P., Kirpotina, L. N., Cilibrizzi, A., & Quinn, M. T. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131218095521 · Cited by 58
“It should be noted that bile acids have multiple physiological functions, including activation of the farnesoid X receptor (FXR) [144] and Takeda G-protein-coupled receptor (TGR5), a G protein-coupled bile acid receptor (GPBAR1) [145].”
BackgroundWan, M., Huang, W., Latawiec, D., Jiang, K., Booth, D. M., Elliott, V., Mukherjee, R., & Xia, Q. (2012) · HPB · doi:10.1111/j.1477-2574.2011.00408.x · Cited by 57
Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease
Yu, Q., Jiang, Z., & Zhang, L. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.04.005 · Cited by 56
Therdtatha, P., Song, Y., Tanaka, M., Mariyatun, M., Almunifah, M., Manurung, N. E. P., Indriarsih, S., Lu, Y., Nagata, K., Fukami, K., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9050897 · Cited by 60
“Dehydroxylated BAs tend to have higher activity for both TGR5 and FXR activations [58], the impairment of BA metabolism in obese subjects appeared to have an adverse impact on metabolic homeostasis.”
BackgroundTabibian, J. H., Masyuk, A. I., Masyuk, T. V., O'Hara, S. P., & LaRusso, N. F. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00495.x · Cited by 52
Kong, B., Sun, R., Huang, M., Chow, M. D., Zhong, X., Xie, W., Lee, Y., & Guo, G. L. (2018) · Hepatology · doi:10.1002/hep.30041 · Cited by 52
“(3,4) BAs can also activate G protein-coupled receptors (GPCRs), including sphingosine 1-phosphate receptor (S1PR) 2 and G protein-coupled bile acid receptor 1 (also called TGR5), to regulate lipid and glucose homeostasis.(5-7) Disorders in BA homeostasis have been implicated in cholestatic liver diseases, fatty liver…”
BackgroundCirculating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction
Leonhardt, J., Haider, R. S., Sponholz, C., Leonhardt, S., Drube, J., Spengler, K., Mihaylov, D., Neugebauer, S., Kiehntopf, M., Lambert, N. A., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.01.011 · Cited by 54
Kovàcs, T., Mikó, E., Ujlaki, G., Yousef, H., Csontos, V., Uray, K., & Bai, P. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10013-3 · Cited by 57
Yang, W., Han, F., Gu, Y., Qu, H. Y., Liu, J., Shen, J., & Leng, Y. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01081-y · Cited by 52
TGR5 in inflammation and cardiovascular disease
Pols, T. W. H. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130279 · Cited by 57
Bhowmik, S., Jones, D. H., Chiu, H., Park, I., Chiu, H., Axelrod, H. L., Farr, C. L., Tien, H. J., Agarwalla, S., & Lesley, S. A. (2014) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.24353 · Cited by 50
Gut Microbiota of Nonalcoholic Fatty Liver Disease
Abdou, R., Zhu, L., Baker, R. D., & Baker, S. S. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4045-1 · Cited by 56
Wang, H., Fang, Z., Meng, R., Cao, Y., Tanaka, N., Krausz, K. W., & Gonzalez, F. J. (2017) · Toxicology · doi:10.1016/j.tox.2017.05.012 · Cited by 56
“1999) involved in cell signaling pathways in the liver and intestine, such as c-Jun N-terminal kinase (JNK) 1/2 to regulate hepatic lipid, glucose, and energy homeostasis, and maintain metabolic homeostasis (Kawamata et al. 2003; Maruyama et al. 2002).”
BackgroundRoles and action mechanisms of bile acid-induced gastric intestinal metaplasia: a review
He, Q., Liu, L., Wei, J., Jiang, J., Rong, Z., Chen, X., Zhao, J., & Jiang, K. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00962-1 · Cited by 64
“Zhen et al. revealed that DCA treatment induced HNF4α expression via TGR5 and following ERK1/2-pathway activation [42].”
BackgroundInfluentialMicrobial regulation of enteroendocrine cells
Arora, T., Vanslette, A. M., Hjorth, S. A., & Bäckhed, F. (2021) · Med · doi:10.1016/j.medj.2021.03.018 · Cited by 59
The Gut Microbiota: A Novel Player in Autoimmune Hepatitis
Cheng, Z., Yang, L., & Chu, H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.947382 · Cited by 55
The Hylemon-Björkhem pathway of bile acid 7-dehydroxylation: history, biochemistry, and microbiology
Ridlon, J. M., Daniel, S. L., & Gaskins, H. R. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100392 · Cited by 54
“Strikingly, derivatives of the hydrophobic secondary bile acid products of microbial 7-dehydroxylation, such as deoxycholic acid (DCA) and lithocholic acid (LCA), are, in general, preferred ligands for many host nuclear receptors (farnesoid X receptor (also known as NR1H4) (6–8), pregnane X receptor (or NR1I2) (9), vi…”
BackgroundGut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Rodrigues, S. G., der Merwe, V., Krag, A. A., & Wiest, R. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2023.101859 · Cited by 57
Fauzi, F. M., Koutsoukas, A., Lowe, R., Joshi, K., Fan, T., Glen, R. C., & Bender, A. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci3005513 · Cited by 57
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity
Biagioli, M., & Carino, A. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_225 · Cited by 56
Lau, B. W., Colella, M., Ruder, W. C., Ranieri, M., Curci, S., & Hofer, A. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.046 · Cited by 55
Liang, H., Matei, N., McBride, D. W., Yang, X., Zhou, Z., Tang, J., Luo, B., & Zhang, J. H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02087-1 · Cited by 54
The Gut Microbiome and Ferroptosis in MAFLD
Ji, J., Wu, L., Wei, J., Wu, J., & Guo, C. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00136 · Cited by 69
Romero‐Ramírez, L., & Mey, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179279 · Cited by 57
“The expression of the TGR5 transcript is very high in monocytes/macrophages [87].”
BackgroundInfluentialXiong, Q., Huang, H., Wang, N., Chen, R., Chen, N., Han, H., Wang, Q., Siwko, S. K., Liu, M., Qian, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02289 · Cited by 51
He, B., Jiang, J., Shi, Z., Wu, L., Yan, J., Chen, Z., Luo, M., Cui, D., Xu, S., Yan, M., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111183 · Cited by 52
Su, C., Liu, X., Li, J., Zhang, M., Pan, L., Lu, Y., Wang, Y., & Ding, Y. (2021) · Aquaculture Nutrition · doi:10.1111/anu.13338 · Cited by 52
Dai, H., Shan, Z., Shi, L., Duan, Y., An, Y., He, C., Lyu, Y., Zhao, Y., Wang, M., Du, Y., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136876 · Cited by 58
Lee, G., Lee, H., Hong, J., Lee, S. H., & Jung, B. H. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.07.017 · Cited by 53
Zhang, Y., Pan, Y., Lin, C., Zheng, Y., Sun, H., Zhang, H., Wang, J., Yuan, M., Duan, T., Du, Q., et al. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw025 · Cited by 50
Elobixibat for the treatment of constipation
Chedid, V., Vijayvargiya, P., & Camilleri, M. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1522248 · Cited by 48
Horiba, T., Katsukawa, M., Mita, M., & Sato, R. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.022 · Cited by 52
“TGR5, a member of the G protein-coupled receptor (GPCR) family, was identified as a lithocholic acid-activated receptor [2,3].”
BackgroundFang, Y., Studer, E. J., Mitchell, C., Grant, S., Pandak, W. M., Hylemon, P. B., & Dent, P. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032060 · Cited by 53
“Two GPCRs have been reported in the literature as receptors for conjugated and, to a lesser extent, unconjugated bile acids: muscarinic family receptors, and the orphan receptor TGR5, with neither report using primary hepatocytes in their studies (Cheng et al., 2002a,b; Raufman et al., 2002; Kawamata et al., 2003; Rau…”
BackgroundΔ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph–ephrin system
Castelli, R., Tognolini, M., Vacondio, F., Incerti, M., Pala, D., Callegari, D., Bertoni, S., Giorgio, C., Hassan‐Mohamed, I., Zanotti, I., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.08.048 · Cited by 48
“The proteineprotein interaction; arnesoid X receptor; TGR5, G -”
BackgroundInfluentialAddressing Unmet Medical Needs in Type 2 Diabetes: A Narrative Review of Drugs under Development
Mittermayer, F., Caveney, E., De Oliveira, C., Gourgiotis, L., Puri, M., Tai, L.-J., & Turner, J. R. (2015) · Current Diabetes Reviews · doi:10.2174/1573399810666141224121927 · Cited by 47
“It was recently discovered that bile salts secreted into the intestines do not only facilitate the absorption of lipids, but also act as signals on at least two receptors, the intracellular nuclear farnesoid X receptor (FXR) [95] and the cell surface Tgr5 G protein-coupled receptor (also known as GPBAR1 and M-BAR) [96…”
BackgroundYang, Z., Xiong, F., Wang, Y., Gong, W., Huang, J., Chen, C., Liu, P., & Huang, H. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.05.035 · Cited by 49
Bile acids and their receptors during liver regeneration: “Dangerous protectors”
Merlen, G., Bedoya, J. U., Bidault, V., Kahale, N., Glénisson, M., Doignon, I., Rainteau, D. P., & Tordjmann, T. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.002 · Cited by 51
“This BA receptor is expressed in numerous cell types and organs (Kawamata et al., 2003; Maruyama et al., 2002), including the liver where its functions essentially remain to be explored (Pols et al.”
BackgroundBile Acids in Hepatic Encephalopathy
DeMorrow, S. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.04.011 · Cited by 50
“Most studies have focused on the Takeda G-protein coupled receptor 5 (TGR5; also known as G-protein coupled bile acid receptor 1; GPBAR1) which can bind and be activated by the unconjugated bile acids lithocholic acid, deoxycholic acid, and chenodeoxycholic acid, increasing intracellular 30,50cyclic adenosine monophos…”
BackgroundMetabolic Effects of Bile Acids: Potential Role in Bariatric Surgery
Flynn, C. R., Albaugh, V. L., & Abumrad, N. N. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.04.014 · Cited by 48
Metadata
- Authors
- Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 11
- Pages
- 9435-9440
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2096418655
- Cited by
- 1,628
- References
- 27
- Citations by year
- 2026: 96 · 2025: 90 · 2024: 114 · 2023: 122 · 2022: 101 · 2021: 114 · 2020: 100 · 2019: 99 · 2018: 108 · 2017: 99 · 2016: 77 · 2015: 76 · 2014: 71 · 2013: 75 · 2012: 50
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6433 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- TGR5, G protein-coupled receptors, bile acids, cell surface receptors, receptor internalization, ERK MAP kinase, cAMP production, macrophages, monocytes, phagocytosis, cytokine production, lipopolysaccharide, THP-1 cells, alveolar macrophages
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Bile Acids and Salts, Cell Line, Cell Membrane, Dose-Response Relationship, Drug, Genetic Vectors, Cricetinae, Humans, Luminescent Proteins, Macrophages, Molecular Sequence Data, Phagocytosis, Protein Binding, Rabbits, Receptors, Cell Surface, Recombinant Fusion Proteins, RNA, Messenger, Time Factors, Tissue Distribution, Transfection, Cytokines, Guanosine 5'-O-(3-Thiotriphosphate), CHO Cells, GTP-Binding Proteins, Reverse Transcriptase Polymerase Chain Reaction, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Receptors, G-Protein-Coupled, Green Fluorescent Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.